Reviakine Ilya
Clin Hemorheol Microcirc. 2015;60(1):133-52. doi: 10.3233/CH-151942.
Recent years have been ripe with discoveries of non-haemostatic platelet functions. This led to the appreciation of the significant, previously unknown, role played by the platelets in various pathologies and regenerative processes. As a result, exciting opportunities for clinical applications in fields as diverse as regenerative medicine and cancer treatment are emerging. However, their realization depends on the understanding of the regulatory mechanisms governing these diverse platelet functions, so that particular platelet responses could be artificially tailored to specific clinical situations. Current understanding of the signalling pathways controlling haemostatic responses is rooted in the development of quantitative assays for measuring them and sensitive markers for their quantification. However, the existing assays and markers are not sufficiently sensitive for distinguishing between individual signalling pathways and unravelling inter-pathway connections. Moreover, entirely new approaches are needed for studying non-haemostatic platelet functions, since there are currently no assays or markers for quantifying them. We review the on-going efforts in these directions, including our own recent work on using lectins as sensitive probes for profiling platelet activation.
近年来,关于非止血性血小板功能的发现层出不穷。这使得人们认识到血小板在各种病理和再生过程中发挥着重要的、此前未知的作用。因此,再生医学和癌症治疗等不同领域的临床应用出现了令人兴奋的机遇。然而,这些机遇的实现取决于对控制这些不同血小板功能的调节机制的理解,以便能够针对特定临床情况人为地调整特定的血小板反应。目前对控制止血反应的信号通路的理解源于用于测量它们的定量测定方法的发展以及用于其定量的敏感标志物。然而,现有的测定方法和标志物对于区分各个信号通路以及揭示通路间的联系不够敏感。此外,由于目前没有用于量化非止血性血小板功能的测定方法或标志物,因此需要全新的方法来研究它们。我们回顾了在这些方向上正在进行的努力,包括我们自己最近关于使用凝集素作为分析血小板活化的敏感探针的工作。